Search news

Showing 15 results

Protein level predicts immunotherapy response in bowel cancer

Research involving UCL scientists has shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy.

24 Jan 2025

UCL welcomes brain cancer researcher and neurosurgeon, Dr Thomas Wälchli

UCL Cancer Institute is pleased to announce the appointment of neurosurgeon and neuroscientist, Dr Thomas Wälchli as an Honorary Consultant Neurosurgeon and Principal Clinical Research Fellow.

02 Jan 2025

UCL cancer researcher receives funding boost via EMBO Young Investigator scheme

A UCL academic based at the Cancer Institute has been chosen as a European Molecular Biology Organisation (EMBO) Young Investigator, a programme that supports young science group leaders in Europe and beyond.

17 Dec 2024

£18m funding boost for London radiation research partnership

The CRUK City of London Radiation Research Centre of Excellence – a partnership uniting leading radiation researchers from UCL, Barts Cancer Institute, King’s College London and The Francis Crick Institute - received the funding to continue world-class radiotherapy research.

30 Oct 2024

New cell signalling finding sheds light on inflammation behind liver cancer

Research led by UCL and the University of Cologne has identified the crucial role played by the LUBAC protein complex in activating a key tumour-promoting signalling pathway, with implications for understanding the biological processes that drive liver cancer progression.

02 Sep 2024

UCL scientists deliver laboratory work experience week

PhD students at UCL have delivered seminars and taught key research techniques to aspiring young scientists as part of a project funded by the Cancer Research UK City of London Centre.

31 Jul 2024

Lung cancer research: Insights into preclinical models

Laboratory models of tumours are widely used and valuable tools for cancer research. However, there are limitations to how well these models can represent the genetic complexity of primary tumours.

31 May 2024

Sergio Quezada and team MATCHMAKERS selected for Cancer Grand Challenges funding

The international team of scientists will aim to decipher the T-cell receptor cancer-recognition code in the latest Cancer Grand Challenges award 2024. Each winning team will receive up to $25m over f

22 Mar 2024

The women behind breakthrough cervical cancer trial

Over the course of 10 years, 500 patients took part in the INTERLACE study at hospitals in the UK, Italy, India, Mexico, and Brazil. Here we meet one of the trial patients, the lead investigator and one of the statisticians tasked with making sense of the data.

02 Feb 2024

Pioneering UK clinical trial for rare cancer receives £1 million of new funding

A UCL/UCLH research team, led by Professor Sandra Strauss, has been awarded the six-figure research grant to continue their pioneering study into osteosarcoma - an aggressive form of bone cancer.

27 Jul 2023

UCL research clinician receives Conquer Cancer Merit Award 2023

Annouced at the 2023 Americal Society of Clinical Oncology (ASCO) annual meeting, Dr Valerie Crolley was awarded the Marcia Mataldi Endowed Merit Award for her abstract on a trial looking at chemotherapy after surgery for cancer of the bile duct or gallbladder (BILCAP)

04 Jul 2023

Baroness Margaret McDonagh

Baroness McDonagh, a former General Secretary of the Labour Party, died on 24 June 2023. Her sister, Siobhain McDonagh, is the Member of Parliament for Mitcham and Morden.

27 Jun 2023

UCL clinician scientist honored with lifetime achievement award

Internationally recognised oncologist, Professor, Siow Ming Lee, has been presented with the British Thoracic Oncology Group (BTOG) Lifetime Achievement Award. The accolade recognises Professor Lee's exceptional contributions to the field of lung cancer research and treatment.

25 May 2023

Researchers discover new compound with potential for treating nerve damage

Research led by UCL, in partnership with the MRC Laboratory of Molecular Biology and AstraZeneca, has identified a new chemical compound that can stimulate nerve regeneration after injury, as well as protect cardiac tissue from the sort of damage seen in heart attack.

24 May 2023

Computer model reveals how early-stage skin cancer can stay ‘invisible’ to immune cells

New research by UCL scientists has shown how melanomas can grow undetected by the body’s immune system, with findings offering a way to identify novel drug combinations to treat the disease.

16 May 2023

Page 1 of 8